Lufeng Y. Zheng

639 Longmian Road
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

pH-responsive chitosan-based nanoparticles for targeted delivery of nicotinamide mononucleotide in acute kidney injury therapy.

pH-responsive chitosan-based nanoparticles for targeted delivery of nicotinamide mononucleotide in acute kidney injury therapy.

Journal: Colloids and surfaces. B, Biointerfaces

Published: May 23, 2026

Spatial multiomics profiling reveals ZFP36-mediated immunometabolic reprogramming in bladder cancer.

Spatial multiomics profiling reveals ZFP36-mediated immunometabolic reprogramming in bladder cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 08, 2026

Targeting breast cancer stem cells by restoring RBM38 function: mechanism and protein delivery therapy.

Targeting breast cancer stem cells by restoring RBM38 function: mechanism and protein delivery therapy.

Journal: Biomarker research

Published: April 01, 2026

Discovery of a Novel Dual-Targeting KRASG12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer.

Discovery of a Novel Dual-Targeting KRASG12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer.

Journal: Journal of medicinal chemistry

Published: February 25, 2026

In silico studies, synthesis, and biological evaluation of novel imidazopyridine-based CYP4Z1 inhibitors targeting breast cancer stem cells.

In silico studies, synthesis, and biological evaluation of novel imidazopyridine-based CYP4Z1 inhibitors targeting breast cancer stem cells.

Journal: European journal of medicinal chemistry

Published: February 14, 2026

Functionalized polysaccharides for infection-resistant and regenerative therapies in gynecology.

Functionalized polysaccharides for infection-resistant and regenerative therapies in gynecology.

Journal: International journal of pharmaceutics: X

Published: January 10, 2026

ISGylation-mediated stabilization of CYP4Z1 fuels breast cancer initiation and progression.

ISGylation-mediated stabilization of CYP4Z1 fuels breast cancer initiation and progression.

Journal: Experimental & molecular medicine

Published: December 20, 2025

Construction of Small-Molecule Deubiquitinase-Targeting Chimeras to Reactivate and Stabilize Mutant p53 Y220C in Vitro and in Vivo.

Construction of Small-Molecule Deubiquitinase-Targeting Chimeras to Reactivate and Stabilize Mutant p53 Y220C in Vitro and in Vivo.

Journal: Angewandte Chemie (International ed. in English)

Published: August 19, 2025

Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: insights from single-cell sequencing.

Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: insights from single-cell sequencing.

Journal: Cancer gene therapy

Published: August 02, 2025

Fluvastatin suppresses breast cancer initiation and progression via targeting CYP4Z1.

Fluvastatin suppresses breast cancer initiation and progression via targeting CYP4Z1.

Journal: Communications biology

Published: May 24, 2025

Lipid-Based Nanoparticles in Cancer Therapy: Advances in Targeted Drug Delivery and Therapeutic Potential for Renal Cell Carcinoma.

Lipid-Based Nanoparticles in Cancer Therapy: Advances in Targeted Drug Delivery and Therapeutic Potential for Renal Cell Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 28, 2025

Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human bladder cancer.

Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human bladder cancer.

Journal: Cancer gene therapy

Published: April 14, 2025

Showing 1-12 of 77

Last Updated: 09/26/2026